Testimony

Every day, AHA staff take to Capitol Hill to tell the hospital story, working to educate Congress on key issues and the field’s concerns. We also advocate with federal regulators, provide expert testimony, and highlight the impact proposed changes could have and suggest alternative solutions. Below are the most recent statements the AHA has submitted for the record for congressional hearings or agency panels.

Latest

AHA statement before the Committee on Ways and Means of the U.S. House of Representatives on : Overcoming Racial Disparities and Social Determinants in the Maternal Mortality Crisis.
Statement of the American Hospital Association for the Committee on Rules of the U.S. House of Representatives
American Hospital Association Statement Before Committee on Education and Labor Subcommittee on Health, Employment, Labor and Pensions
AHA Statement Before the House Committee on the Judiciary’s Subcommittee on Antitrust, Commercial and Administrative Law Exploring the Effects of Consolidation and Anticompetitive Conduct in Health Care Markets
Testimony for House Committee on Energy and Commerce Subcommittee on Oversight and Investigations, October 11, 2017.
Testimony of Dr. Charles Daniels House Energy and Commerce Committee 340B Oversight Hearing, July 11, 2018.
The AHA appreciates the opportunity to provide input regarding action Congress can take to maintain access to quality, affordable health care in rural communities.
Statement of the American Hospital Association before the Subcommittee on Health of the Committee on Energy and Commerce of the U.S. House of Representatives providing input on the implementation of the Merit-based Incentive Payment System, which is part of the Quality Payment Program mandated by the Medicare Access and CHIP Reauthorization Act of 2015.
AHA statement before the House Committee on Ways and Means, Subcommittee on Health regarding "Modernizing Stark Law to Ensure the Successful Transition from Volume to Value in the Medicare Program."
AHA testimony before the House Committee on Oversight and Government Reform regarding cybersecurity threats facing hospitals, health systems and the health care field. 
AHA statement before the Senate Committee on Health, Education, Labor and Pensions on Reducing Health Care Costs: Eliminating Excess Health Care Spending and Improving Quality and Value for Patients.”
AHA statement before the House Energy and Commerce Subcommittee on Communications and Technology: Realizing the Benefits of Rural Broadband: Challenges and Solutions.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, including more than 1,900 hospitals that participate in the 340B drug savings program, and our cl
AHA statement before the Senate Committee on Health, Education, Labor and Pensions: Hearing on How to Reduce Health Care Costs: Understanding the Cost of Health Care in America”
AHA statement before the Senate Finance Committee on Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market.
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions regarding “Effective Administration of the 340B Drug Pricing Program.”
AHA Statement to the Committee on Ways and Means for “Hearing on Lowering Costs and Expanding Access to Health Care through Consumer-Directed Health Plans.”
AHA statement before the Senate Finance Committee on "Rural Health Care in America: Challenges and Opportunities."
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions: Examining Oversight Reports on the 340B Drug Pricing Program